/Investor DB

IQ Capital — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Neurovalensneurovalens.comin𝕏Apr 2024

Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders.

BiotechDeep TechHealthtechMedical DevicesMental HealthNorthern Ireland, GB

Dr. Jason McKeown(MD PhD, Founder)

Co-investorsACF InvestorsClarendon Fund Managers Ltd.StartXBeltrae PartnersBritish Business BankInnovation Ulster+2 more

Tagomicstagomics.comFeb 2024

Tagomics develops multimodal technologies for precision medicine and next-generation diagnostics.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, GB

Dr Jack Kennefick(Co-founder, Director & Chief Executive Officer)Dr Robert Neely(Co-founder, Director & Chief Scientific Officer)

Co-investorsCalculus Capital Ltd.Illumina VenturesStart CodonCalculusIllumina InnovationInnovate UK+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.